BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16099066)

  • 1. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.
    Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB
    Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes.
    Whitehead SS; Firestone CY; Collins PL; Murphy BR
    Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL
    J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures.
    Schickli JH; Kaur J; Tang RS
    Virus Res; 2012 Oct; 169(1):38-47. PubMed ID: 22771939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.
    Connors M; Crowe JE; Firestone CY; Murphy BR; Collins PL
    Virology; 1995 Apr; 208(2):478-84. PubMed ID: 7747420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
    Blaney JE; Johnson DH; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
    J Virol; 2001 Oct; 75(20):9731-40. PubMed ID: 11559806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type I IFNs in the in vitro attenuation of live, temperature-sensitive vaccine strains of human respiratory syncytial virus.
    Loveys DA; Kulkarni S; Atreya PL
    Virology; 2000 Jun; 271(2):390-400. PubMed ID: 10860892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA.
    Butrapet S; Kinney RM; Huang CY
    J Virol Methods; 2006 Jan; 131(1):1-9. PubMed ID: 16087248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
    Luongo C; Winter CC; Collins PL; Buchholz UJ
    J Virol; 2012 Oct; 86(19):10792-804. PubMed ID: 22837193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
    Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
    Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
    Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR
    Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.
    Elliott MB; Pryharski KS; Yu Q; Parks CL; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
    J Virol; 2004 Jun; 78(11):5773-83. PubMed ID: 15140975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 16. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.
    Whitehead SS; Firestone CY; Karron RA; Crowe JE; Elkins WR; Collins PL; Murphy BR
    J Virol; 1999 Feb; 73(2):871-7. PubMed ID: 9882287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated influenza vaccines in young seronegative children.
    Wright PF; Kervina M; Thompson J; Torrence AE; Karzon DT
    Dev Biol Stand; 1977 Jun 1-3; 39():99-103. PubMed ID: 604140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
    Nelson CL; Tang RS; Stillman EA
    Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated temperature-sensitive respiratory syncytial virus mutants generated by cold adaptation.
    Randolph VB; Kandis M; Stemler-Higgins P; Kennelly MS; McMullen YM; Speelman DJ; Weeks-Levy C
    Virus Res; 1994 Sep; 33(3):241-59. PubMed ID: 7985411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.